Prevalence and clinical significance of organ-specific autoantibodies in type I diabetes mellitus

Netherlands Journal of Medicine

Volumn 65, Issue 7, 2007, Pages 235-247

  De Graaff, L C G ^a   Smit, J W A ^a   Radder, J K ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Autoimmune antibodies; Organ specific dysfunction; Type I diabetes mellitus

Indexed keywords

ANTIGEN; AUTOANTIBODY; ENDOMYSIUM ANTIBODY; PARIETAL CELL ANTIBODY; THYROGLOBULIN ANTIBODY; THYROID ANTIBODY; THYROID PEROXIDASE ANTIBODY;

ACHLORHYDRIA; ADDISON DISEASE; AGE; ANTIBODY TITER; ATROPHIC GASTRITIS; AUTOIMMUNE DISEASE; CELIAC DISEASE; DIAGNOSTIC VALUE; GENDER; HASHIMOTO DISEASE; HUMAN; HYPERGASTRINEMIA; HYPOTHYROIDISM; INSULIN DEPENDENT DIABETES MELLITUS; MULTIPLE ORGAN FAILURE; PERNICIOUS ANEMIA; PREDICTION; RACE; REVIEW; RISK ASSESSMENT; STOMACH DISEASE;

AUTOANTIBODIES; AUTOIMMUNE DISEASES; DIABETES COMPLICATIONS; DIABETES MELLITUS, TYPE 1; GASTROINTESTINAL TRACT; HUMANS; PREVALENCE; THYROID GLAND;

EID: 34547729160     PISSN: 03002977     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (162)

1. Greenspan FS. Basic and Clinical Endocrinology. New York, Appleton and Lange, 1993.
2. Baker JR Jr. Autoimmune endocrine disease. JAMA 1997;278:1931-7.
3. Brink SJ. Complications of pediatric and adolescent type 1 diabetes mellitus. Curr Diab Rep 2001;1:47-55.
4. Loomans CJ, de Koning EJ, Staal FJ, et al. Endothelial progenitor cell dysfunction: a novel concept in the pathogenesis of vascular complications of type 1 diabetes. Diabetes 2004;53:195-9.
5. Bingley PJ. Prediction of IDDM in the general population: strategies based on combinations of autoantibody markers. Diabetes 1997;46:1701-10.
6. Todd JA, Bell JI, McDevitt HO. HLA-DQ beta gene contributes to susceptibility and resistance to insulin-dependent diabetes mellitus. Nature 1987;6140:599-604.
7. Bilbao JR, Martin-Pagola A, Perez De Nanclares, G et al. HLA-DRB1 and MICA in autoimmunity: common associated alleles in autoimmune disorders. Ann N Y Acad Sci 2003;1005:314-8.
8. Heimberg H, Nagy ZP, Somers G, et al. Complementation of HLA-DQA and -DQB genes confers susceptibility and protection to insulin-dependent diabetes mellitus. Hum Immunol 1992;33:10-7.
9. Johansson S, Lie BA, Todd JA, et al. Evidence of at least two type 1 diabetes susceptibility genes in the HLA complex distinct from HLA-DQB1, -DQA1 and -DRB1. Genes Immun 2003;4:46-53.
10. Kanga U, Vaidyanathan B, Jaini R, et al. HLA haplotypes associated with type 1 diabetes mellitus in North Indian children. Hum Immunol 2004;65:47-53.
11. De Vries RE, Roep BO. Clinical and preclinical immunology of type 1 diabetes. Neth J Med 1998;53:127-9.
12. Hiemstra HS, Schloot NC, van Veelen PA, et al. Cytomegalovirus in autoimmunity: T cell crossreactivity to viral antigen and autoantigen glutamic acid decarboxylase. Proc Natl Acad Sci USA 2001;98:3988-91.
13. Ziegler AG, Schmid S, Huber D, Hummel M, Bonifacio E. Early infant feeding and risk of developing type 1 diabetes-associated autoantibodies. JAMA 2003;290:1721-8.
14. Presotto F, Betterle C. Insulin-dependent diabetes mellitus: a constellation of autoimmune diseases. J Ped End Metab 1997;10:455-69.
15. Roitt I. Immunology. 5th ed. London: Mosby, 1998.
16. Bilimoria KY, Pescovitz OH, DiMeglio. LA Autoimmune thyroid dysfunction in children with type 1 diabetes mellitus: screening guidelines based on a retrospective analysis. J Ped End Metab 2003;16:1111-7.
17. Kordonouri O, Klinghammer A, Lang EB, Gruters-Kieslich A, Grabert M, Holl RW. Thyroid autoimmunity in children and adolescents with type 1 diabetes: a multicenter survey. Diabetes Care 2002;25:1346-50.
18. Lindberg B, Ericsson UB, Ljung R, Ivarsson SA. High prevalence of thyroid autoantibodies at diagnosis of insulin-dependent diabetes mellitus in Swedish children. J Lab Clin Med 1997;130:585-9.
19. Trimarchi F, de Luca F, Vanelli M, et al. Circulating thyroid antibodies and thyroid function studies in children and adolescents with insulin-dependent diabetes mellitus. Eur J Pediatr 1984;142:253-6.
20. Boscaro M, Betterle C, Sonino N, Volpato M, Paoletta A, Fallo F. Early adrenal hypofunction in patients with organ-specific autoantibodies and no clinical adrenal insufficiency. J Clin Endocrinol Metab 1994;79:452-5.
21. Robles DT, Fain PR, Gottlieb PA, Eisenbarth GS. The genetics of autoimmune polyendocrine syndrome type II. Endocrinol Metab Clin North Am 2002;31:353-68.
22. De Block CE, de Leeuw IH, Bogers JJ, et al. Autoimmune gastropathy in type 1 diabetic patients with parietal cell antibodies: histological and clinical findings. Diabetes Care 2003;26:82-8.
23. Riley WJ, Winer A, Goldstein D. Coincident presence of thyro-gastric autoimmunity at onset of type 1 (insulin-dependent) diabetes, Diabetologia 1983;24:418-21.
24. Aktay AN, Lee PC, Kumar V, Parton E, Wyatt DT, Werlin SL. The prevalence and clinical characteristics of coeliac disease in juvenile diabetes in Wisconsin. J Pediatr Gastroenterol Nutr 2001;33:462-5.
25. Holmes GK. Screening for coeliac disease in type 1 diabetes. Arch Dis Child 2002;87:495-8.
26. Talal AH, Murray JA, Goeken JA, Sivitz WI. Coeliac disease in an adult population with insulin-dependent diabetes mellitus: use of endomysial antibody testing. Am J Gastroenterol 1997;92:1280-4.
27. Betterle C, Zanchetta R. Update on autoimmune polyendocrine syndromes (APS) Acta Biomed Ateneo Parmense 2003;74:9-33.
28. Wilson JD. Williams textbook of endocrinology. 9th ed. Philadelphia: WB Saunders, 1998.
29. Papadopoulos KI, Hallengren B. Polyglandular autoimmune syndrome type III associated with coeliac disease and sarcoidosis. Postgrad Med J 1993;69:72-5.
30. Collin P, Kaukinen K, Valimaki M Salmi J. Endocrinological disorders and coeliac disease. Endocr Rev 2002;23:464-83.
31. Dittmar M, Kahaly GJ. Polyglandular autoimmune syndromes: immunogenetics and long-term follow-up. J Clin Endocrinol Metab 2003;88:2983-92.
32. Roep BO. The role of T-cells in the pathogenesis of Type 1 diabetes: From cause to cure. Diabetologia 2003;46:305-21.
33. Brunt LM. Immunologic disorders of the thyroid gland and autoimmune polyendocrinopathies. In: Samter M (ed). Immunologic diseases. 5th ed. Boston: Little, Brown and Company, 1998, pp 975-93.
34. Bernet V. Autoimmune thyroid disease. In: Rich RR (ed) Clinical Immunology, London: Mosby, 1998.
35. 4 binding to thyroperoxidase in Hashimoto's thyroiditis. Endocrinology 2003;144:5422-9.
36. Bright GM, Blizzard RM, Kaiser DL, Clarke WL. Organ-specific autoantibodies in children with common endocrine diseases. J Pediatr 1982;100:8-14.
37. Chang YH, Hwang J, Shang HF, Tsai ST. Characterization of human DNA topoisomerase II as an autoantigen recognized by patients with IDDM. Diabetes 1996;45:408-14.
38. Frasier SD, Penny R, Snyder R, Goldstein I, Graves D. Antithyroid antibodies in Hispanic patients with type I diabetes mellitus. Prevalence and significance. Am J Dis Child 1986;140:1278-80.
39. Kokkonen J, Kiuttu J, Mustonen A, Rasanen O. Organ-specific antibodies in healthy and diabetic children and young adults. Acta Paediatr Scand 1982;71:223-6.
40. Lorini R, Larizza D, Livieri C, et al. Auto-immunity in children with diabetes mellitus and in their relatives. Eur J Pediatr 1986;145:182-4.
41. Magzoub MM, Abdel-Hameed AA, Bottazzo GF. Prevalence of islet cell and thyrogastric autoantibodies in Sudanese patients with type 1 diabetes. Diabet Med 1994;11:188-92.
42. McKenna MJ, Herskowitz R, Wolfsdorf JI. Screening for thyroid disease in children with IDDM. Diabetes Care 1990;13:801-3.
43. Odugbesan O, Fletcher JA, Sanders A, Bradwell AR, Botazzo GF, Barnett AH. Autoantibodies in Indian-Asians with insulin-dependent diabetes in the UK. Postgrad Med J 1988;64:357-60.
44. Rattarasarn C, Diosdado MA, Ortego J, et al. Thyroid autoantibodies in Thai type 1 diabetic patients: clinical significance and their relationship with glutamic acid decarboxylase antibodies. Diabetes Res Clin Pract 200;49:107-11.
45. Roldan MB, Alonso M, Barrio R. Thyroid autoimmunity in children and adolescents with Type 1 diabetes mellitus. Diabetes Nutr Metab 1999;12:27-31.
46. Shiau MY, Tsai ST, Hwang J, Wu CY, Chang YH. Relationship between autoantibodies against glutamic acid decarboxylase, thyroglobulin/ thyroid microsome and DNA topoisomerase II in the clinical manifestation of patients with type 1 diabetes mellitus in Taiwan. Eur J Endocrinol. 2000;142:577-85.
47. Vakeva A, Kontiainen S, Miettinen A, Schlenzka A, Maenpaa J. Thyroid peroxidase antibodies in children with autoimmune thyroiditis. J Clin Pathol 1992;45:106-9.
48. Walikonis JE, Lennon VA. Radioimmunoassay for glutamic acid decarboxylase (GAD65) autoantibodies as a diagnostic aid for stiff-man syndrome and a correlate of susceptibility to type 1 diabetes mellitus. Mayo Clin Proc 1998;73:1161-6.
49. Betterle C, Zanette F, Pedini B, et al. Clinical and subclinical organ-specific autoimmune manifestations in type 1 (insulin-dependent) diabetic patients and their first-degree relatives. Diabetologia 1984;26:431-6.
50. Riley WJ, Maclaren NK, Lezotte DC, Spillar RP, Rosenbloom AL. Thyroid autoimmunity in insulin-dependent diabetes mellitus: the case for routine screening. J Pediatr 1981;99:350-4.
51. De Block CE, de Leeuw IH, van Gaal LF. High prevalence of manifestations of gastric autoimmunity in parietal cell antibody-positive type 1 (insulin-dependent) diabetic patients. The Belgian Diabetes Registry. J Clin Endocrinol Metab 1999;84:4062-7.
52. Gilani BB, MacGillivray MH, Voorhess ML, Mills BJ, Riley WJ, Maclaren NK. Thyroid hormone abnormalities at diagnosis of insulin-dependent diabetes mellitus in children. J Pediatr 1984;105:218-22.
53. Hagglof B, Rabinovitch A, Mackay P, et al. Islet cell and other organ-specific autoantibodies in healthy first-degree relatives to insulin-dependent. Acta Paediatr Scand 1986;75:611-8.
54. Ketchum CH, Riley WJ, Maclaren NK. Adrenal dysfunction in asymptomatic patients with adrenocortical autoantibodies. J Clin Endocrinol Metab 1984;58:1166-70.
55. Neufeld M, Maclaren NK, Riley WJ, et al. Islet cell and other organ-specific antibodies in U.S. Caucasians and Blacks with insulin-dependent diabetes mellitus. Diabetes 1980;29:589-92.
56. Riley WJ, Maclaren NK, Lezotte DC, Spillar RP, Rosenbloom AL. Thyroid autoimmunity in insulin-dependent diabetes mellitus: the case for routine screening. J Pediatr 1981;99:350-4.
57. Riley WJ, Toskes PP, Maclaren NK, Silverstein JH. Predictive value of gastric parietal cell autoantibodies as a marker for gastric and hematologic abnormalities associated with insulin-dependent diabetes. Diabetes 1982;31:1051-5.
58. Winter WE, Maclaren NK, Riley WJ, Unger RH, Neufeld M, Ozand PT. Pancreatic alpha cell autoantibodies and glucagon response to arginine. Diabetes 1984;33:435-7.
59. Hanukoglu A, Mizrachi A, Dalal I, et al. Extrapancreatic autoimmune manifestations in type 1 diabetes patients and their first-degree relatives: a multicenter study. Diabetes Care 2003;26:1235-40.
60. Jaeger C, Natziagelaki E, Petzoldt R, Bretzel RG. Comparative analysis of organ-specific autoantibodies and coeliac disease-associated antibodies in type 1 diabetic patients, their first-degree relatives, and healthy control subjects. Diabetes Care 2001;24:27-32.
61. Landin-Olsson M, Karlsson A, Dahlquist G, Blom L, Lernmark A, Sundkvist G. Islet cell and other organ-specific autoantibodies in all children developing type 1 (insulin-dependent) diabetes mellitus in Sweden during one year and in matched control children. Diabetologia 1989;32:387-95.
62. Roman SH, Davies TF, Witt ME, Ginsberg-Fellner F, Rubinstein P. Thyroid autoantibodies in HLA-genotyped type 1 diabetic families: sex-limited DR5 association with thyroid microsomal antibody. Clin Endocrinol (Oxf) 1986;25:23-33.
63. Triggiani V, Ciampolillo A, Guastamacchia E, et al. Prospective study of post-partum thyroid immune dysfunctions in type 1 diabetic women and in a healthy control group living in a mild iodine deficient area. Immunopharmacol Immunotoxicol 2004;26:215-24.
64. Chang CC, Huang CN, Chuang LM.Autoantibodies to thyroid peroxidase in patients with type 1 diabetes in Taiwan. Eur J Endocrinol 1998;139:44-8.
65. De Block CE, de Leeuw IH, Decochez K, et al. The presence of thyrogastric antibodies in first degree relatives of type 1 diabetic patients is associated with age and proband antibody status. J Clin Endocrinol Metab 2001;86:4358-63.
66. Hansen D, Bennedbaek FN, Hansen LK, Hoier-Madsen M, Jacobsen BB, Hegedus L. Thyroid function, morphology and autoimmunity in young patients with insulin-dependent diabetes mellitus. Eur J Endocrinol 1999;140:512-8.
67. Hansen D, Bennedbaek FN, Hoier-Madsen M, Hegedus L, Jacobsen BB. A prospective study of thyroid function, morphology and autoimmunity in young patients with type 1 diabetes. Eur J Endocrinol 2003;148:245-51.
68. Mochizuki M, Amemiya S, Kobayashi K, et al. Association of the CTLA-4 gene 49 A/G polymorphism with type 1 diabetes and autoimmune thyroid disease in Japanese children. Diabetes Care 2003;26:843-7.
69. De Block CE, de Leeuw IH, Vertommen JJ, et al. Beta-cell, thyroid, gastric, adrenal and coeliac autoimmunity and HLA-DQ types in type 1 diabetes. Clin Exp Immunol 2001;126:236-41.
70. Kobayashi T, Sawano S, Sugimoto T, et al. Islet-cell antibodies in IDDM and NIDDM in a Japanese population. Tohoku J Exp Med 1983;141(Suppl):271-4.
71. Maclaren NK, Riley WJ. Thyroid, gastric, and adrenal autoimmunities associated with insulin-dependent diabetes mellitus. Diabetes Care 1985;8(Suppl 1):34-8.
72. Cardoso C, Ohwovoriole AE, KuKu SF. A study of thyroid function and prevalence of thyroid autoantibodies in an African diabetic population. J Diabetes Complications 1995;9:37-41.
73. Verge CF, Howard NJ, Rowley MJ, et al. Anti-glutamate decarboxylase and other antibodies at the onset of childhood IDDM: a population-based study. Diabetologia 1994;37:1113-20.
74. Abrams P, de Leeuw I, Vertommen J. In new-onset insulin-dependent diabetic patients the presence of anti-thyroid peroxidase antibodies is associated with islet cell autoimmunity and the high risk haplotype HLA DQAI*0301-DQB1*0302. Belgian Diabetes Registry. Diabet Med 1996;13:415-9.
75. Holl RW, Bohm B, Loos U, Grabert M, Heinze E, Homoki J. Thyroid autoimmunity in children and adolescents with type 1 diabetes mellitus. Effect of age, gender and HLA type. Horm Res 1999;52:113-8.
76. Alonso N, Granada ML, Salinas I, et al. Serum pepsinogen I: an early marker of pernicious anemia in patients with type 1 diabetes. J Clin Endocrinol Metab 2005;90:5254-8.
77. Verge CF, Howard NJ, Rowley MJ, et al. Anti-glutamate decarboxylase and other antibodies at the onset of childhood IDDM: a population-based study. Diabetologia 1994;37:1113-20.
78. Glastras SJ, Craig ME, Verge CF, Chan AK, Cusumano JM, Donaghue KC. The role of autoimmunity at diagnosis of type 1 diabetes in the development of thyroid and coeliac disease and microvascular complications. Diabetes Care 2005;28:2170-5.
79. Gallas PR, Stolk RP, Bakker K, Endert E, Wiersinga WM. Thyroid dysfunction during pregnancy and in the first postpartum year in women with diabetes mellitus type 1. Eur J Endocrinol 2002;147:443-51.
80. Burek CL, Rose NR, Guire KE, Hoffman WH. Thyroid autoantibodies in black and in white children and adolescents with type 1 diabetes mellitus and their first degree relatives. Autoimmunity 1990;7:157-67.
81. Bergamaschini L, Gardinali M, Poll M, Lorini R, Bosi E, Agostoni A. Complement activation in diabetes mellitus. J Clin Lab Immunol 1991;35:121-7.
82. Chen BH, Chung SB, Chiang W, Chao MC. GAD65 antibody prevalence and association with thyroid antibodies, HLA-DR in Chinese children with type 1 diabetes mellitus. Diabetes Res Clin Pract 2001;54:27-32.
83. Davis RE, McCann VJ, Stanton KG. Type 1 diabetes and latent pernicious anaemia. Med J Aust 1992;156:160-2.
84. Fernandez-Castaner M, Molina A, Lopez-Jimenez L, Gomez JM, Soler J. Clinical presentation and early course of type 1 diabetes in patients with and without thyroid autoimmunity. Diabetes Care 1999;22-:377-81.
85. Snajderova M, Martinek J, Horejsi J, Novakova D, Lebl J, Kolouskova S. Premenarchal and postmenarchal girls with insulin-dependent diabetes mellitus: ovarian and other organ-specific autoantibodies, menstrual cycle. J Pediatr Adolesc Gynecol 1999;12:209-14.
86. Yokota I, Matsuda J, Naito E, Ito M, Shima K, Kuroda Y. Comparison of GAD and ICA512/IA-2 antibodies at and after the onset of IDDM. Diabetes Care 1998;21:49-52.
87. Hansen D, Bennedbaek FN, Hansen LK, et al. High prevalence of coeliac disease in Danish children with type I diabetes mellitus. Acta Paediatr 2001;90:1238-43.
88. Kim EY, Shin CH, Yang SW. Polymorphisms of HLA class II predispose children and adolescents with type 1 diabetes mellitus to autoimmune thyroid disease. Autoimmunity 2003;36:177-81.
89. Park YS, Kim TW, Kim WB, Cho BY. Increased prevalence of autoimmune thyroid disease in patients with type 1 diabetes. Korean J Intern Med 2000;15:202-10.
90. Kaino Y, Kida K, Goto Y, et al. Thyroglobulin antibodies in type 1 diabetic patients and their relatives: measurement with highly sensitive assay. Diabetes Res Clin Pract 1994;22:147-54.
91. Hansen D, Bennedbaek FN, Hansen LK, Hoier-Madsen M, Jacobsen BB, Hegedus L. Thyroid function, morphology and autoimmunity in young patients with insulin-dependent diabetes mellitus. Eur J Endocrinol 1999;140:512-8.
92. Landin-Olsson M and Karlsson FA, Lernmark A Sundkvist G. Islet cell and thyrogastric antibodies in 633 consecutive 15- to 34-yr-old patients in the diabetes incidence study in Sweden. Diabetes 1992;41:1022-7.
93. Barker JM, Yu J, Yu L, et al. Autoantibody "subspecificity" in type 1 diabetes: risk for organ-specific autoimmunity clusters in distinct groups. Diabetes Care 2005;28:850-5.
94. Park Y, Kim S, Park S, et al. Differential expression of nonislet autoimmunity: comparison of Korean and U.S. patients with type 1 diabetes. Ann N Y Acad Sci 2004;1037:69-73.
95. Betterle C, Callegari G, Presotto F, et al. Thyroid autoantibodies: a good marker for the study of symptomless autoimmune thyroiditis. Acta Endocrinol (Copenh) 1987;114:321-7.
96. Court S, Parkin JM. Hypothyroidism and growth failure in diabetes mellitus. Arch Dis Child 1982;57:622-4.
97. Falorni A, Calcinaro F. Autoantibody profile and epitope mapping in latent autoimmune diabetes in adults. Ann N Y Acad Sci 2002;958:99-106.
98. Hathout EH, Hartwick N, Fagoaga OR, et al. Clinical, autoimmune, and HLA characteristics of children diagnosed with type 1 diabetes before 5 years of age. Pediatrics 2003;111:860-3.
99. Kordonouri O, Deiss D, Danne T, Dorow A, Bassir C, Gruters-Kieslich A. Predictivity of thyroid autoantibodies for the development of thyroid disorders in children and adolescents with Type 1 diabetes. Diabet Med 2002;19:518-21.
100. Umpierrez GE, Latif KA, Murphy MB, et al. Thyroid dysfunction in patients with type 1 diabetes: a longitudinal study. Diabetes Care 2003;26:1181-5.
101. McCanlies E, O'Leary LA, Foley TP, et al. Hashimoto's thyroiditis and insulin-dependent diabetes mellitus: differences among individuals with and without abnormal thyroid function. J Clin Endocrinol Metab 1998;83:1548-51.
102. Gomez JM, Maravall FJ, Guma A, Abos R, Soler J, Fernandez-Castaner M. Thyroid volume as measured by ultrasonography in patients with type 1 diabetes mellitus without thyroid dysfunction. Horm Metab Res 2003;35:486-91.
103. Blecher M. Receptors, antibodies, and disease. Clin Chem 1984;30:1137-56.
104. Karlsson FA, Kampe O, Winqvist O, Burman P. Autoimmune disease of the adrenal cortex, pituitary, parathyroid glands and gastric mucosa. J Intern Med 1993;234:379-86.
105. Alonso N, Granada ML, Salinas I, et al. Serum pepsinogen I: an early marker of pernicious anemia in patients with type 1 diabetes. J Clin Endocrinol Metab 2005;90:5254-8.
106. Strober W, Neurath MF. Immunologic diseases of the gastrointestinal tract. In: Rich RR (ed). Clinical Immunology. London: Mosby, 1998. pp 1408-23
107. Brown WR. Immunologic diseases of the gastrointestinal tract. In: Samter M (ed) Immunologic diseases. 5th ed. Boston: Little, Brown and Company, 1998. pp 1158-65
108. Schade SG, Cohen RJ Conrad ME. Effect of hydrochloric acid on iron absorption. N Engl J Med 1968;279:672-4.
109. Sipponen P, Valle J, Varis K, Kekki M, Ihamaki T, Siurala M. Fasting Levels of serum gastrin in different functional and morphologic states of the antrofundal mucosa. An analysis of 860 subjects. Scand J Gastroenterol 1990;25:513-9.
110. Toh BH, Sentry JW, Alderuccio F. The causative H+/K+ ATPase antigen in the pathogenesis of autoimmune gastritis. Immunol Today 2000;21:348-54.
111. Karlsson FA, Burman P, Loof L, Olsson M, Scheynius A, Mardh S. Enzyme-linked immunosorbent assay of H+,K+-ATPase, the parietal cell antigen. Clin Exp Immunol. 1987;70:604-10.
112. Kokkonen J. Parietal cell antibodies and gastric secretion in children with diabetes mellitus. Acta Paediatr Scand 1980;69:485-9.
113. Ramachandran A, Rosenbloom AL, Mohan V, et al. Autoimmunity in South Indian patients with IDDM. Diabetes Care 1986;9:435-6.
114. Trudeau WL, McGuigan JE. Relations between serum gastrin levels and rates of gastric hydrochloric acid secretion. N Engl J Med 1971;284:408-12.
115. Sipponen P, Harkonen M, Alanko A, Suovaniemi O. Diagnosis of atrophic gastritis from a serum sample. Minerva Gastroenterol Dietol 2003;49:11-21.
116. Vaananen H, Vauhkonen M, Helske T, et al. Non-endoscopic diagnosis of atrophic gastritis with a blood test. Correlation between gastric histology and serum levels of gastrin-17 and pepsinogen I: a multicentre study. Eur J Gastroenterol Hepatol 2003;15:885-91.
117. Kuipers EJ. In through the out door: serology for atrophic gastritis. Eur J Gastroenterol Hepatol 2003;15:877-9.
118. Botazzo GF. Adrenalitis, oophoritis and autoimmune polyglandular disease. In: Rich (ed). Clinical immunology. London: Mosby, 1998. pp. 1523-35.
119. Peterson P, Salmi H, Hyoty H, et al. Steroid 21-hydroxylase autoantibodies in insulin-dependent diabetes mellitus. Childhood Diabetes in Finland (DiMe) Study Group. Clin Immunol Immunopathol 1997;82:37-42.
120. Falorni A, Laureti S, Nikoshkov A, et al. 21-hydroxylase autoantibodies in adult patients with endocrine autoimmune diseases are highly specific for Addison's disease. Belgian Diabetes Registry. Clin Exp Immunol 1997;107:341-6.
121. Tandon N, Shtauvere-Brameus A, Hagopian WA, Sanjeevi CB. Prevalence of ICA-12 and other autoantibodies in north Indian patients with early-onset diabetes. Ann N Y Acad Sci 2002;958:214-7.
122. Yu L, Brewer KW, Gates S, et al. DRB1*04 and DQ alleles: expression of 21-hydroxylase autoantibodies and risk of progression to Addison's disease. J Clin Endocrinol Metab 1999;84:328-35.
123. Riley WJ, Maclaren NK, Neufeld M. Adrenal autoantibodies and Addison disease in insulin-dependent diabetes mellitus. J Pediatr 1980;97:191-5.
124. Betterle C, Scalici C, Presotto F, et al. The natural history of adrenal function in autoimmune patients with adrenal autoantibodies. J Endocrinol 1988;117:467-75.
125. Del Rosario MA, Fitzgerald JF, Chong SK, Croffie JM, Gupta SK. Further studies of anti-endomysium and anti-gliadin antibodies in patients with suspected coeliac disease. J Pediatr Gastroenterol Nutr 1998;27:191-5.
126. Cronin CC, Feighery A, Ferriss JB, Liddy C, Shanahan F, Feighery C. High prevalence of coeliac disease among patients with insulin-dependent (type I) diabetes mellitus. Am J Gastroenterol 1997;92:2210-2.
127. Shamir R. Advances in coeliac disease. Gastroenterol Clin North Am 2003;32:931-47.
128. Korponay-Szabo IR, Halttunen T, Szalai Z, et al. In vivo targeting of intestinal and extraintestinal transglutaminase 2 by coeliac autoantibodies. Gut 2004;53:641-8.
129. Weile B, Grodzinsky E, Skogh T, Jordal R, Cavell B, Krasilnikoff PA. Screening Danish blood donors for antigliadin and antiendomysium antibodies. Acta Paediatr 1996;412:46.
130. Volta U, Molinaro N, Fusconi M, Cassani F, Bianchi FB. IgA antiendomysial antibody test. A step forward in coeliac disease screening. Dig Dis Sci 1991;36:752-6.
131. Brown WR. Immunologic diseases of the gastrointestinal tract. In: Samter M (ed) Immunologic diseases. 5th ed. Boston: Little, Brown and Company, 1998. pp 1158-65.
132. Sategna-Guidetti C, Grosso S, Pulitano R, Benaduce E, Dani F, Carta Q. Coeliac disease and insulin-dependent diabetes mellitus. Screening in an adult population. Dig Dis Sci 1994;39:1633-7.
133. Carlsson AK, Axelsson IE, Borulf SK, et al. Prevalence of IgA-antiendomysium and IgA-antigliadin autoantibodies at diagnosis of insulin-dependent diabetes mellitus in Swedish children and adolescents. Pediatrics 1999; 103:1248-52.
134. Doolan A, Donaghue K, Fairchild J, Wong M, Williams AJ. Use of HLA typing in diagnosing coeliac disease in patients with type 1 diabetes. Diabetes Care 2005;28:806-9.
135. Prazny M, Skrha J, Limanova Z, et al. Screening for associated autoimmunity in type 1 diabetes mellitus with respect to diabetes control. Physiol Res 2005;54:41-8.
136. Shahbazkhani B, Faezi T, Akbari MR, et al. Coeliac disease in Iranian type I diabetic patients. Dig Liver Dis 2004;36:191-4.
137. Aygun C, Uraz S, Damci T, et al. Coeliac disease in an adult Turkish population with type 1 diabetes mellitus. Dig Dis Sci 2005;50:1462-6.
138. Schober E, Bittmann B, Granditsch G, et al. Screening by anti-endomysium antibody for coeliac disease in diabetic children and adolescents in Austria. Pediatr GastroenteroI Nutr 2000;30:391-6.
139. Barera G, Bianchi C, Calisti L, et al. Screening of diabetic children for coeliac disease with antigliadin antibodies and HLA typing. Arch Dis Child 1991;66:491-4.
140. Barera G, Bonfanti R, Viscardi M, et al. Occurrence of coeliac disease after onset of type 1 diabetes: a 6-year prospective longitudinal study. Pediatrics 2000;109:833-8.
141. Crone J, Rami B, Huber WD, Granditsch G, Schober E. Prevalence of coeliac disease and follow-up of EMA in children and adolescents with type 1 diabetes mellitus. J Pediatr Gastroenterol Nutr 2003;37:67-71.
142. Sumnik Z, Kolouskova S, Cinek O, Kotalova R, Vavrinec J, Snajderova M. HLA-DQA1*05-DQB1*0201 positivity predisposes to coeliac disease in Czech diabetic children. Acta Paediatr 2000;89:1426-30.
143. Sjoberg K, Eriksson KF, Bredberg A, Wassmuth R, Eriksson S. Screening for coeliac disease in adult insulin-dependent diabetes mellitus. J Intern Med 1998;243:133-40.
144. Rensch MJ, Merenich JA, Lieberman M, Long BD, Davis DR, McNally PR. Gluten-sensitive enteropathy in patients with insulin-dependent diabetes mellitus. Ann Intern Med 1996;124:564-7.
145. Acerini CL, Ahmed ML, Ross KM, Sullivan PB, Bird G, Dunger DB. Coeliac disease in children and adolescents with IDDM: clinical characteristics and response to gluten-free diet. Diabet Med 1998;15:38-44.
146. Cerutti F, Bruno G, Sacchetti C, Rabbone I, Cavallo F, Ansaldi N. Risk for silent coeliac disease is higher in diabetic children with a diabetic sibling than in sporadic cases. Diabetes Care 2000;23:1027-8.
147. Arato A, Korner A, Veres G, Dezsofi A, Ujpal I, Madacsy L. Frequency of coeliac disease in Hungarian children with type 1 diabetes mellitus. Eur J Pediatr 2003;162:1-5.
148. Kordonouri O, Dieterich W, Schuppan D, et al. Autoantibodies to tissue transglutaminase are sensitive serological parameters for detecting silent coeliac disease in patients with Type 1 diabetes mellitus. Diabet Med 2000;17:441-4.
149. Roldan MB, Barrio R, Roy G, et al. Diagnostic value of serological markers for coeliac disease in diabetic children and adolescents. J Pediatr Endocrinol Metab 1998;11:751-6.
150. Fraser-Reynolds KA, Butzner JD, Stephure DK, Trussell RA, Scott RB. Use of immunoglobulin A-antiendomysial antibody to screen for coeliac disease in North American children with type 1 diabetes. Diabetes Care 1998;21:1985-9.
151. Li Voon Chong JS, Leong KS, Wallymahmed M, Sturgess R, MacFarlane IA. Is coeliac disease more prevalent in young adults with coexisting Type 1 diabetes mellitus and autoimmune thyroid disease compared with those with Type 1 diabetes mellitus alone? Diabet Med 2002;19:334-7.
152. Martin-Villa JM, Lopez-Suarez JC, Perez-Blas M, et al. Coeliac- and enteropathy-associated autoantibodies in Spanish insulin-dependent diabetes mellitus patients and their relation to HLA antigens. J Diabetes Complications 2001;15:38-43.
153. Peretti N, Bienvenu F, Bouvet C, et al. The temporal relationship between the onset of type 1 diabetes and coeliac disease: a study based on immunoglobulin a antitransglutaminase screening. Pediatrics 2004;113:e418-22.
154. Vitoria JC, Castano L, Rica I, Bilbao JR, Arrieta A, Garcia-Masdevall MD. Association of insulin-dependent diabetes mellitus and coeliac disease: a study based on serologic markers. J Pediatr Gastroenterol Nutr 1998;27:47-52.
155. Buysschaert M, Tomasi JP, Hermans MP. Prospective screening for biopsy proven coeliac disease, autoimmunity and malabsorption markers in Belgian subjects with Type 1 diabetes. Diabet Med 2005;22:889-92.
156. Mahmud FH, Murray JA Kudva YC, et al. Coeliac disease in type 1 diabetes mellitus in a North American community: prevalence, serologic screening, and clinical features. Mayo Clin Proc 2005;80:1429-34.
157. Picarelli A, Sabbatella L, Di Tola M, Vetrano S, Casale C, Anania MC. Anti-endomysial antibody of IgG1 isotype detection strongly increases the prevalence of coeliac disease in patients affected by type I diabetes mellitus. Clin Exp Immunol 2005;142:111-5.
158. Sakly W, Bienvenu F, Peretti N, et al. IgA anti-transglutaminase antibodies as a tool for screening atypical forms of coeliac disease in a French at-risk paediatric population. Eur J Gastroenterol Hepatol 2005;17:235-9.
159. Sategna-Guidetti C, Grosso S, Pulitano R, Benaduce E, Dani F, Carta Q. Coeliac disease and insulin-dependent diabetes mellitus. Screening in an adult population. Dig Dis Sci 1994;39:1633-7.
160. Cerutti F, Bruno G, Chiarelli F, Lorini R, Meschi F, Sacchetti C. Younger age at onset and sex predict coeliac disease in children and adolescents with type 1 diabetes: an Italian multicenter study. Diabetes Care 2004;27:1294-8.
161. Schober E, Rami B, Granditsch G, Crone J. Coeliac disease in children and adolescents with type 1 diabetes mellitus: to screen or not, to treat or not? Horm Res 2002; 57 Suppl 1:97-100.
162. Ashabani A, Abushofa U, Abusrewill S, Abdelazez M, Tuckova L, Tlaskalova-Hogenova H. The prevalence of coeliac disease in Libyan children with type 1 diabetes mellitus. Diabetes Metab Res Rev 2003;19:69-75.